Loading
institutionsInstitution
Kliniken Essen-Mitte
Essen hospital whose gynaecological oncology department runs the German AGO ovarian cancer trials and whose medical oncologists led RAINBOW in stomach cancer.
Also called: KEMEvang. Kliniken Essen-MitteEvangelische Huyssens-Stiftung
Overview
Kliniken Essen-Mitte is a Protestant hospital group in Essen. Its Department of Gynecology and Gynecologic Oncology, led by Andreas du Bois and Philipp Harter, is the coordinating centre of the AGO Study Group and ran the DESKTOP III surgery trial and the PAOLA-1 and PRIMA-era maintenance studies in ovarian cancer. The medical oncology department, where Hansjochen Wilke practised, led RAINBOW, the 2014 trial that established ramucirumab plus paclitaxel as second-line treatment in advanced gastric cancer.
Location
Essen, DE
Type
hospital
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#526 · 6 points (0 Newsweek + 0 NCI + 6 from 3 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Kliniken Essen-Mitte, including child institutions. 242 works · 3,383 citations · 76% open access · 20% clinical trials · 0% reviews.
Oncology works per year
582022
512023
602024
462025
272026
Most works
- Philipp Harter49 works
- Florian Heitz44 works
- Ignace B. Vergote40 works
- Éric Pujade-Lauraine34 works
- Nicoletta Colombo32 works
- Isabelle L. Ray-Coquard28 works
- Antonio González-Martı́n23 works
- Nadia Harbeck21 works
- Sandro Pignata21 works
- Carsten Denkert20 works
Most cited
- Gynaecological oncology (AGO Study Group)
- Ovarian cancer surgery trials
- Gastrointestinal oncology
Andreas du Bois
Director of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte; Chair, AGO Study Group
Ovarian cancer surgeryCooperative-group trialsCytoreductive surgery
Surgeon who chairs the German AGO group and led DESKTOP III, proving secondary surgery can extend survival in selected relapsed ovarian cancer.
Hansjochen Wilke
Medical oncologist, Kliniken Essen-Mitte
Gastric cancerAnti-angiogenic therapySecond-line chemotherapy
German oncologist who led RAINBOW, the trial that made ramucirumab plus paclitaxel a standard second-line treatment for advanced stomach cancer.